CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-06). The draft was written by AI, all 9 cited sources were opened and checked for existence, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 002 · Search date 2026-07-06 · Methodology v0.6

Glutathione,
does it really help with Whitening and skin tone?

30-Second Summary
C
Evidence Grade C · Safety acceptable
There are small studies, but they conflict with one another, and no study has ever shown the full path through to "it becomes brighter because you take it orally"
What the
research shows
There are a few human studies on whitening with oral glutathione, but most are small and short-term (4-12 weeks), and on instrument-measured skin-brightness indicators (melanin index), the results were either not significant overall or improved only in some sites or in a specific age group. Crucially, the studies that examined whitening did not measure blood glutathione, so those studies did not confirm within the study itself "whether what was taken orally was actually absorbed and acted."
What the
ads claim
Advertisements talk about "skin whitening," "tone-up," and "glass-bead glow after one use." What the studies showed extends only to small indicator changes under some conditions, and in this review we did not find evidence supporting "definite whitening." In addition, whitening is not a function recognized by the MFDS for glutathione.
*

Useful facts when choosing a product

  • "Adhesive or dissolving films" and "oral (swallowed) products" have different evidence. Films applied to the skin or dissolved in the mouth have absorption routes different from swallowed capsules, so studies on one side cannot be used as evidence for the other side. Advertisements often mix the two.
  • The labeled amount and the actual amount may differ. In a 2024 Korea Consumer Agency survey, among 7 products that displayed glutathione content, 5 had actual glutathione at about half of the labeled or advertised amount. In some cases, the total amount of "yeast extract" was written as if it were pure glutathione.
  • "99% purity" is not evidence of effect. Purity is only raw-material quality; it is a different matter from evidence that there is a whitening effect in humans.
  • "Whitening" is not a function recognized by the MFDS for glutathione. Commercial oral glutathione is classified as a general food, not as a health functional food. (In a 2024 Korea Consumer Agency and MFDS survey, 59 out of 100 online advertisements were detected as improper advertisements.)
  • Injection (IV) and taking it orally are different. Studies of intravenous glutathione cannot be used as evidence for oral products. Injectable products are not approved for whitening purposes.
Gap Measurement · Verdict 002 · C
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Randomized controlled trials (RCTs) of oral glutathione for whitening do in fact exist. However, they are small and short, and most are surrogate indicators in which skin brightness is measured by a machine.

Separately, there are studies that examined whether it is absorbed when taken orally (Richie 2015: oral intake increased body glutathione stores by 30-35%). However, this study did not measure whitening. The most recent absorption study (2026) reported that absorption of ordinary swallowed oral formulations was low and that only a special formulation was better. In summary, the studies that showed absorption did not look at whitening, and the studies that looked at whitening did not look at absorption, so "it becomes brighter because you take it orally" has never been connected within one study. We present these two facts as they are. Interpretation is up to the reader.

Arjinpathana 2012 — oral 500 mg/day for 4 weeks, 60 participants. Among melanin-index measurements at 6 sites, only 2 sun-exposed sites were significant versus placebo (face p=0.021, left forearm p=0.036), and the rest showed no significant difference. Blood glutathione was not measured.

Weschawalit 2017 — 250 mg/day for 12 weeks. It was not statistically significant in the full participant group (p>0.05), and was significant only in a subgroup over 40 years old and at a specific site (p=0.031). Funding and the test product were provided by the glutathione manufacturer Kyowa Hakko Bio.

Sitohang 2021 — glutathione + vitamin C + alpha-lipoic acid + zinc combination capsule for 12 weeks. There was a magnitude of improvement, but it was not statistically significant. Manufacturer (Mazta Farma) funding. Because it was a combination product, the effect cannot be attributed to glutathione alone.

02

Why this is classified as C

The TrueValue grade does not mean whether an effect is "good" or "bad"; it indicates how high the evidence reaches in the evidence hierarchy and how independently it exists.

Why it is not D or F. Several actual double-blind RCTs exist, and directional signals are repeatedly observed under some conditions. This is not a level with no evidence at all.

Why it is not B. That signal is (1) based on surrogate indicators and small effect sizes, (2) seen only in subgroups and some sites rather than overall, (3) not closed from absorption to effect within a single study, (4) all verified whitening RCTs were manufacturer-funded, and (5) whitening is not a regulatorily recognized function. Beyond "human RCTs exist, but the share of industry funding is high" (B), this corresponds to C, where the evidence is conflicting and limited.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Arjinpathana N, Asawanonda P 2012Double-blind/RCT60AbsorptionOral RCT, 500 mg/day for 4 weeks, 60 participants. Only 2 sun-exposed sites were significant for the melanin index. Blood GSH not measured. Flags B1 (surrogate indicator) and D1 (absorption not confirmed). Initial AI-proposed DOI error corrected against the original source.Key
Weschawalit S et al. 2017RCTOral RCT, 250 mg/day for 12 weeks. No overall significance (p>0.05), only subgroup p=0.031. Flags A1 (manufacturer Kyowa Hakko funding and product, inconsistent with the "no conflicts of interest" declaration), A2, and B1.Key
Sitohang IBS et al. 2021RCTOral RCT, combination capsule for 12 weeks. Not statistically significant. Flags A1 (Mazta Farma funding), B2 (RCT but failed to prove efficacy), and D1 (combination product; cannot attribute to glutathione).Key
Wahab S et al. 2021RCTOral + topical combination RCT. Reported improvement in surrogate indicators. Flags E3 (mixed formulations — cannot isolate oral-only effect) and B1.Key
Richie JP Jr et al. 2015RCT54Intestine and absorptionOral RCT, 250/1000 mg for 6 months, 54 participants. Body GSH stores increased by 30-35%. Whitening not measured. Flags E4 (proves absorption only; must not be repurposed as whitening evidence) and A1 (Kyowa Hakko/Setria).Supporting
Study 6RCT14AbsorptionOral absorption RCT, 14-participant crossover. The standard swallowed formulation had low absorption and only the special formulation was superior. Whitening not measured. Flags E4, A1 (ISURA/Factors Group), and B1.Supporting
Buonocore D et al. 2016AbsorptionOromucosal formulation absorption study. Whitening not measured. Flags E3 (oromucosal ≠ swallowed oral) and E4.Supporting
Sitohang IBS, Ninditya S 2020Systematic reviewAbsorptionReview. Oral results were only partly significant in subgroups, and IV (Zubair 2016) had poor results (no significant difference from placebo). Explicitly states that "oral GSH is broken down into amino acids before absorption." Flags B2 (secondary literature) and route (oral/IV distinction).Supporting
Sharma DK, Sharma P 2022AbsorptionReview. Summarized that "swallowed oral bioavailability is low, and oromucosal absorption is high." Flags E3 (do not misuse the oromucosal 80% figure as swallowed oral evidence) and B2.Supporting
§

Receipt — 9 References

Every cited source was opened and checked against the live page on 2026-07-06.

Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. J Dermatolog Treat 2012 · PMID 20524875 · pubmed.ncbi.nlm.nih.gov/20524875
checked
Weschawalit S, et al. Glutathione and its antiaging and antimelanogenic effects. Clin Cosmet Investig Dermatol 2017 · PMID 28490897 · PMC5413479
checked
Sitohang IBS, et al. Evaluating Oral Glutathione Plus Ascorbic Acid, Alpha-lipoic Acid, and Zinc Aspartate as a Skin-lightening Agent. J Clin Aesthet Dermatol 2021 · PMID 34840651 · PMC8570360
checked
Wahab S, et al. Combination of topical and oral glutathione as a skin-whitening agent. Int J Dermatol 2021;60(8):1013–1018 · DOI 10.1111/ijd.15573 · wiley.com
checked
Richie JP Jr, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr 2015;54(2):251–263 · PMID 24791752 · pubmed.ncbi.nlm.nih.gov/24791752
checked
Reference 6
checked
Buonocore D, et al. Bioavailability Study of an Innovative Orobuccal Formulation of Glutathione. Oxid Med Cell Longev 2016:3286365 · PMC4663342
checked
Reference 8
checked
Sharma DK, Sharma P. Augmented Glutathione Absorption from Oral Mucosa and its Effect on Skin. Clin Cosmet Investig Dermatol 2022 · PMC9473545
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-06 · Corrections: none

Cite this verdict

Oral glutathione × whitening Evidence Grade C card
[Chamgap] Oral glutathione × whitening — Evidence Grade C. 9 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/skin-hair/glutathione-whitening/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.